Workplace Outreach Program Improves Management of Chronic Kidney Disease

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Olga A. Iakoubova ◽  
Carmen H. Tong ◽  
Charles M. Rowland ◽  
Andre R. Arellano ◽  
Lance A. Bare ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Outreach Program

scholarly journals Vanderbilt O'Brien Kidney Center

2020 ◽  
Author(s):  
Ambra Pozzi ◽  
Raymond C Harris
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Scientific Community ◽  
State Of The Art ◽  
Kidney Diseases ◽  
The United States ◽  
Outreach Program ◽  
Personalized Care ◽  
Education And Outreach ◽  
The Right

The Vanderbilt O'Brien Kidney Center (VOKC) is one of the eight NDDK-P30 funded Centers in the United States. The mission of these core-based Centers is to provide technical and conceptual support to enhance and facilitate research in the field of kidney diseases. The goal of the VOKC is to provide support to understand mechanisms and identify potential therapies for acute and chronic kidney disease. The services provided by the VOKC are meant to help the scientific community to have the right support and tools as well as to select the right animal model, statistical analysis, and clinical study design to perform innovative research and translate discoveries into personalized care to prevent, diagnose and cure kidney disease. To achieve these goals, the VCKD has in place a program to foster collaborative investigation into critical questions of kidney disease; to personalize diagnosis and treatment of kidney disease; and to disseminate information about kidney disease and the benefits of the VOKC services and research. The Center is complemented by state-of-the art Cores and an Education and Outreach program whose goals are to provide an educational platform to enhance the study of kidney disease; to publicize information about services available through the VOKC; and to provide information about kidney disease to patients and other interested members of the community. In this review we highlight the major services and contributions of the VOKC.

scholarly journals Prevalence of Hypertension and Diabetes and Coexistence of Chronic Kidney Disease and Cardiovascular Risk in the Population of the Republic of Moldova

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Igor Codreanu ◽  
Vera Sali ◽  
Sergiu Gaibu ◽  
Luminita Suveica ◽  
Sergiu Popa ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Renal Disease ◽  
Screening Program ◽  
Outreach Program ◽  
Renal Disease Progression ◽  
Middle Income ◽  
Republic Of Moldova ◽  
The Republic ◽  
Stage Renal Disease

In 2005, the International Society of Nephrology (ISN) established the Global Outreach Program (GO) aimed at building a capacity for detecting and managing chronic kidney disease and its complications in low- and middle-income countries. Here we report data from the 2006-2007 screening program (1025 subjects from the general population) in the Republic of Moldova aimed to determine the prevalence of hypertension, diabetes, and their coexistence with microalbuminuria. The likelihood of a serious cardiovascular (CV) event was also estimated. Hypertension and diabetes were very common among screened subjects. The prevalence of microalbuminuria was 16.9% and that of estimated GFR <60 ml/min/1.73 m2(decreased renal function) was 9.4%. Male gender was associated with an increased prevalence of hypertension and microalbuminuria. Hypertension and diabetes clustered in subjects with microalbuminuria and renal dysfunction. Risk factors such as preobesity/obesity, physical inactivity and smoking were relatively common, even in younger participants. The prevalence of subjects with predicted 10-year CV risk≥10% was 10.0%. In conclusion, in the Republic of Moldova patients with hypertension and diabetes should be screened for the coexistence of renal abnormalities, with the intention of developing disease-specific health-care interventions with the primary goal to reduce CV morbidity and mortality and prevent renal disease progression to end stage renal disease.

No effect of vitamin D supplementation on metabolic parameters but on lipids in patients with type 2 diabetes and chronic kidney disease

2020 ◽  
pp. 1-10
Author(s):  
Jiwoon Kim ◽  
Ji Sun Nam ◽  
Heejung Kim ◽  
Hye Sun Lee ◽  
Jung Eun Lee
Keyword(s):  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Vitamin D ◽  
Kidney Disease ◽  
Vitamin D Supplementation ◽  
Lipid Profiles ◽  
Metabolic Parameters ◽  
Injection Group ◽  
Different Doses

Abstract. Background/Aims: Trials on the effects of cholecalciferol supplementation in type 2 diabetes with chronic kidney disease patients were underexplored. Therefore, the aim of this study was to investigate the effects of two different doses of vitamin D supplementation on serum 25-hydroxyvitamin D [25(OH)D] concentrations and metabolic parameters in vitamin D-deficient Korean diabetes patients with chronic kidney disease. Methods: 92 patients completed this study: the placebo group (A, n = 33), the oral cholecalciferol 1,000 IU/day group (B, n = 34), or the single 200,000 IU injection group (C, n = 25, equivalent to 2,000 IU/day). 52% of the patients had less than 60 mL/min/1.73m2 of glomerular filtration rates. Laboratory test and pulse wave velocity were performed before and after supplementation. Results: After 12 weeks, serum 25(OH)D concentrations of the patients who received vitamin D supplementation were significantly increased (A, -2.4 ± 1.2 ng/mL vs. B, 10.7 ± 1.2 ng/mL vs. C, 14.6 ± 1.7 ng/mL; p < 0.001). In addition, the lipid profiles in the vitamin D injection group (C) showed a significant decrease in triglyceride and a rise in HDL cholesterol. However, the other parameters showed no differences. Conclusions: Our data indicated that two different doses and routes of vitamin D administration significantly and safely increased serum 25(OH)D concentrations in vitamin D-deficient diabetes patients with comorbid chronic kidney disease. In the group that received the higher vitamin D dose, the lipid profiles showed significant improvement, but there were no beneficial effects on other metabolic parameters.

Ankle-brachial index in chronic kidney disease

VASA ◽  
2012 ◽  
Vol 41 (3) ◽  
pp. 159-160
Author(s):  
Espinola-Klein ◽  
F. Dopheide ◽  
Gori
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Ankle Brachial Index
Sign in / Sign up

Export Citation Format

Share Document